Highlights of the leading international meeting on sleep disorders, which starts this weekend

SEATTLE -- Trials of novel interventions to promote compliance with continuous positive airway pressure (CPAP) in sleep apnea and evaluations of different approaches to cognitive behavioral therapy for insomnia will command attention here as researchers and clinicians gather for the year's most important sleep medicine conference.

SLEEP 2015, the joint annual meeting of the American Academy of Sleep Medicine and the Sleep Research Society, will feature some 1,200 original research presentations as well as panel discussions, symposia, and lectures by leading figures in sleep medicine. General sessions begin Sunday and continue through Wednesday; postgraduate courses are on Saturday.

Nonpharmacological treatments for jet lag, including a transcranial bright light system

Studies of napping as a therapeutic intervention

Investigations into the adverse effects of sleep deprivation

Secondary analyses of data from the pivotal trials of suvorexant, the insomnia drug approved last year and sold as Belsomra

Data on other agents with a similar mechanism of action including E2006 and MK-1064

Also on tap are sessions on topical issues, including a panel discussion on how legalized marijuana -- the host city being a location where recreational cannabis is sold legally -- may affect clinical sleep medicine as well as health policy.

Accessibility Statement

At MedPage Today, we are committed to ensuring that individuals with disabilities can access all of the content offered by MedPage Today through our website and other properties. If you are having trouble accessing www.medpagetoday.com, MedPageToday's mobile apps, please email legal@ziffdavis.com for assistance. Please put "ADA Inquiry" in the subject line of your email.